Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008041. doi: 10.1002/14651858.CD008041.pub2
Methods Multicentre, randomised, double-blind, placebo-controlled, parallel-group. Single oral dose per attack. Participants treated two migraine attacks
Medication taken when migraine headache pain of moderate or severe intensity
Assessments at 0 and 2 hours.
If pain not controlled, participants asked to wait 2 hours before taking rescue medication
Participants Aged 18-65 years, meeting IHS criteria for migraine with or without aura. At least 12-month history of migraine, with two to six attacks per month for three months prior to inclusion in study. Prophylaxis permitted if stable for ≥3 months
Excluded participants whose migraine headache was never accompanied by nausea or vomiting N = 266 (250 analysed for efficacy, 16 did not take medication)
M = 46, F = 220
Mean age 37 years
Interventions Lysine acetylsalicylate 1650 mg (equivalent to 900 mg aspirin) plus metoclopramide 10 mg, n = 126
Placebo, n = 124
Outcomes Headache relief at 2 hours
Pain-free at 2 hours
PI: 4-point scale
Presence of nausea and vomiting
Headache recurrence at 24 hours
PGE: 4-point scale
Use of rescue medications
Notes Oxford Quality Score: R1, DB1, W1. Total = 3.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Not described
Allocation concealment? Unclear Not described
Blinding?
All outcomes
Unclear Not described